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Abstract
Background: In the working age group, diabetic retinopathy is a leading cause of visual impairment. Regular eye
examinations and early treatment of retinopathy can prevent visual loss, so screening for diabetic retinopathy is
cost-effective. Dilated retinal digital photography with the additional use of ophthalmoscopy is the most effective
and robust method of diabetic retinopathy screening. The aim of this study was to estimate the sensitivity and
specificity of diabetic retinopathy screening when performed by Norwegian optometrists.
Methods: This study employed a cross-sectional experimental design. Seventy-four optometrists working in private
optometric practice were asked to screen 14 single-field retinal images for possible diabetic retinopathy. The
screening was undertaken using a web-based visual identification and management of ophthalmological
conditions (VIMOC) examination. The images used in the VIMOC examination were selected from a population
survey and had been previously examined by two independent ophthalmologists. In order to establish a “gold
standard”, images were only chosen for use in the VIMOC examination if they had elicited diagnostic agreement
between the two independent ophthalmologists. To reduce the possibility of falsely high specificity occurring by
chance, half the presented images were of retinas that were not affected by diabetic retinopathy. Sensitivity and
specificity for diabetic retinopathy was calculated with 95% confidence intervals (CIs).
Results: The mean (95%CI) sensitivity for identifying eyes with any diabetic retinopathy was 67% (62% to 72%). The
mean (95%CI) specificity for identifying eyes without diabetic retinopathy was 84% (80% to 89%). The mean (95%CI)
sensitivity for identifying eyes with mild non-proliferative diabetic retinopathy or moderate non-proliferative
diabetes was 54% (47% to 61%) and 100%, respectively. Only four optometrists (5%) met the required standard of
at least 80% sensitivity and 95% specificity that has been previously set for diabetic retinopathy screening
programmes.
Conclusions: The evaluation of retinal images for diabetic retinopathy by Norwegian optometrists does not meet
the required screening standard of at least 80% sensitivity and 95% specificity. The introduction of measures to
improve this situation could have implications for both formal optometric training and continuing optometric
professional education.
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Background
Approximately 90,000 to 120,000 Norwegians have known
diabetes [1], among whom reported prevalence of diabetic
retinopathy (DR) ranges from 11% to 28% [2-5]. In the
working age group, DR is a leading cause of visual impair-
ment [6]. Among people with diabetes, 1% to 13% develop
sight-threatening diabetic retinopathy (STDR) and 0.4% to
1.3% are visually impaired because of DR [7-13]. Regular
eye examinations and early treatment of retinopathy can
prevent visual loss [9,14-16], so screening for DR is cost-
effective [17]. Dilated retinal digital photography with the
additional use of ophthalmoscopy is the most effective and
robust method of DR screening [18,19]. In Norway, the
national guidelines for diabetes [20] and The Norwegian
College of General Practitioners [21] recommend either
regular eye examinations by an ophthalmologist or the use
of retinal photography. The Norwegian Association of Op-
tometry has issued clinical guidelines for optometric prac-
tice [22] which include guidelines for the examination and
management of patients with diabetes.
People with diabetes are commonly examined in opto-
metric practice due to having refractive errors. Norwegian
optometric practice may represent a low threshold setting
for case-finding of DR [23]. Studies in other countries have
shown that optometrists are able to detect and grade DR
[24] and specially trained optometrists perform well when
screening for STDR (sensitivity 73%-97% and specificity
83%-99%) [25-29]. Since 1988, the profession in Norway
has developed from being populated by opticians to being
an approved healthcare profession, populated by optome-
trists. Consequently, Norwegian optometrists are a hetero-
geneous group with regard to formal education [30]. In
2004, optometrists were granted the right to prescribe
diagnostic ocular drugs and since 2009 they have been
able to refer patients directly to an ophthalmologist, with-
out the patient first seeing a gate-keeping general practi-
tioner (GP). These two responsibilities warrant a high
standard of performance on the part of the optometrist.
Sensitivity and specificity define the ability of a clinical
test to correctly identify people with and without a specific
disease. For low prevalence diseases, a high specificity is
required to avoid large numbers of false positive results.
The British Diabetic Association (now Diabetes UK) has
set a required screening standard for DR of at least 80%
sensitivity and 95% specificity [31]. The aims of the
current study were to assess the sensitivity and specificity
of the optometrists’ diagnosis of DR and to assess sensitiv-
ity and specificity with respect to the optometrists’ formal
education. Furthermore, we wanted to investigate how the
optometrists intended to follow up their cases.
Methods
A cross-sectional experimental design was employed. The
study population, from which study participants were
drawn, comprised authorized optometrists in Norway
(n≈1850). Members of the Norwegian Association of Op-
tometry (NOF) (n=1028) were invited to participate by
e-mail. Only those optometrists who were currently work-
ing in private practice, who had worked in private practice
for the previous 6 months and who intended to continue
working in private practice for the following 6 months
were eligible for inclusion in the study.
Those optometrists who responded positively to our e-
mail and were subsequently accepted for inclusion in the
study were sent an interactive web-based visual identifica-
tion and management of ophthalmological conditions
(VIMOC) examination that used Question Writer 4 soft-
ware. A VIMOC examination tests clinical competency
using cases and/or images with accompanying multiple
choice questions [32]. The examination consisted of 14
retinal images which the optometrists were to assess with
respect to the presence or absence of DR, without grading
severity. Additionally, they were to decide on patient man-
agement, based solely on retinal findings and making
the assumption that the patient had never been examined
by an ophthalmologist. No grading scales or patient
management guidelines were provided and the optome-
trists were not given any patient information, such as
visual acuity data. It was possible to move back and forth
in the VIMOC exam to review the images and revise
prior assessments before submitting a final response. In
addition, a questionnaire was included to gather informa-
tion regarding the participants’ work experience, educa-
tion, preferred method of retinal examination, methods
used for retinal examination in patients with diabetes, and
methods available to them for retinal examination and im-
aging. Optometrists used their own computers with screen
resolution and colour set to maximum. Screen resolution
ranged from 1024×600 to 2560×1440 pixels.
The VIMOC retinal images were obtained from a pre-
vious Norwegian population survey [2]. The study fol-
lowed the tenets of the Declaration of Helsinki for
research involving humans and was approved by the Re-
gional Committee for Medical Research Ethics, REC
Central (January 19. 2009). Blinded to patient informa-
tion, all images had been independently assessed by two
ophthalmologists who graded the presence of retinop-
athy according to the Diabetic Retinopathy Disease Se-
verity Scale [33]. The ophthalmologists viewed the
images on a 21” monitor with screen resolution of
1600×1200 pixels. From a total of 239 images, only those
that had been graded with full agreement between the
two ophthalmologists (n=217) were considered for inclu-
sion in our study. Seven images of retinas affected by
non-proliferative diabetic retinopathy (NPDR) and seven
images of retinas unaffected by DR were randomly
selected. The DR images included five examples of mild
NPDR (Figure 1) and two examples of moderate,
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potentially sight threatening NPDR (Figure 2). To reduce
the possibility of falsely high specificity occurring by
chance, half of the presented images were of retinas that
were not affected by DR. The diagnoses of the two
ophthalmologists for each image were used as a “gold
standard” against which the performance of the study
participants was assessed.
The required sample size of participants was calcu-
lated based on the following: 50% prevalence of DR in
the image sample, a standard deviation of true sensitivity
and specificity for individual optometrists’ image evalu-
ation of 0.2, and 50% sensitivity and specificity for
detecting DR by individual optometrists to allow max-
imum variance. It was calculated that a CI < 0.05 for
sensitivity and specificity for any diabetic retinopathy
(ADR) could be achieved with 100 study participants,
meaning that sensitivity and specificity was calculated
with 95% confidence interval for any retinopathy. Study
participants were not asked to grade DR; the sensitivity
of mild and moderate NPDR was assessed in terms of
detection of retinopathy in images with mild and moder-
ate NPDR, respectively. The screening standard estab-
lished by the British Diabetic Association (Diabetes UK)
of at least 80% sensitivity and 95% specificity for ADR
[31] was used as the screening standard in our study.
Potential associations between test performance and for-
mal education were investigated and analysed using
Pearson Chi-square and student-t tests; a p-value ≤ 0.05
was regarded as significant.
Data were collected in the period between 28th February
and 14th March 2011; reminders requesting participants to
complete the test were sent once.
Results
In all, 112 (11%) members of NOF responded positively
to the e-mail and volunteered to participate in this
study. Of these 112, 101 (90%) met the inclusion criteria,
and 74 (73%) completed the study. Participants were
generally educated to a higher level than the average for
Norwegian optometrists (Table 1).
The optometrists’ preferred methods of retinal examin-
ation were reported to include undilated indirect ophthal-
moscopy (47% of participants) and undilated retinal
fundus photography (34% of participants). Multiple exam-
ination methods were reported for patients with diabetes
(Table 2). Twenty-three percent of participants reported
that they undertook dilated retinal examinations in
patients with diabetes.
The optometrists’ assessments of each of the 14
VIMOC images are presented in Table 3. Optometrists
with higher optometric education (a Master of Science
in clinical optometry [MSc]) demonstrated significantly
higher sensitivity than those who had a basic optometric
education (Table 4). The specificity was not influenced
by the optometrist education level.
No association was found either between sensitivity or
specificity and the number of years of experience in opto-
metric practice, or between sensitivity or specificity and
the participants’ preferred method of retinal examination.
The screening standard for sensitivity of at least 80% and
specificity of at least 95%, for ADR, was met by 24 (32%)
and 31 (42%) optometrists, respectively, overall. The stan-
dards for sensitivity and specificity were met by 50% and
45%, respectively, of optometrists who held an MSc and
by 25% and 39%, respectively, who had a basic optometric
Figure 1 Mild non-proliferative diabetic retinopathy.
Figure 2 Moderate non-proliferative diabetic retinopathy.
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education. Only four optometrists (5%) met the required
standard for both sensitivity and specificity.
Patient management decisions were dependent on retinal
findings (Table 5). Report/referral to a GP and/or an oph-
thalmologist was regarded as appropriate for 99% and 96%
of true- and false-positive findings, respectively. The rate of
referral to an ophthalmologist was higher for moderate
than for mild NPDR (92% vs. 62%). No further manage-
ment was considered appropriate in 68% and 66% of cases
of true- and false-negative findings, respectively.
Discussion
Only 5% of the responding optometrists satisfied the
screening standard established by the British Diabetic
Association of at least 80% sensitivity and 95% specificity
[31]. Overall, sensitivity for detecting ADR was low and
specificity was moderate. Sensitivity for detecting poten-
tial STDR was, however, high. This suggests that the
optometrists’ assessment of retinal images is an unreli-
able method of screening for DR. The sensitivity and
specificity of detection of DR in the current study and
previous studies is presented in Table 6. It is not possible
to make a direct comparison between the current study
and previous studies that involved community optome-
trists [28,34], as those studies did not report sensitivity
and specificity levels for individual optometrists. How-
ever, based on the reported mean levels of sensitivity
and specificity, it is unlikely that individual optometrists
in those studies would have met the British Diabetic
Association screening criteria. The sensitivity for detect-
ing ADR in our study (67%) was lower than that
reported by Gibbins et al. (86-88%) [28]. However, the
sensitivity for detecting STDR was higher in our study
than in either the Gibbins et al. or Buxton et al studies
(100% vs. 47-97%) [28,34] and the specificity was similar
(84% vs. 83-95%). The greater sensitivity for detecting
STDR in the current study could have been a result of
the higher prevalence of STDR in our VIMOC sample
compared with these earlier studies, which may have
inflated sensitivity by chance. The prevalence of ADR in
our study was comparable with the prevalence of ADR
in the study by Gibbins et al. [28]. In that study, opto-
metrists had received special training in the identifica-
tion and grading of DR, which could explain the
relatively high sensitivity levels observed.
Table 2 Characteristics of participating optometrists by
formal education
Master of
science in clinical
optometrya
All
(n=74)
No
(n=51)
Yes
(n=22)
Gender, n (%)
Female 43 (58) 30 (59) 13 (59)
Male 31 (42) 21 (41) 9 (41)
Number of years as practicing optometrist,
mean (sd) **
12 (±9) 10 (±8) 16 (±8)
Preferred method of retinal examination, n
(%)
Undilated indirect ophthalmoscopy 35 (47) 22 (43) 13 (59)
Retinal fundus photography 25 (34) 16 (31) 8 (36)
Undilated direct ophthalmoscopy 9 (12) 9 (17) 0 (0)
Other 5 (7) 4 (8) 1 (1)
Retinal examinations methods used in
patients with diabetes, n (%)
Undilated retinal photography 46 (62) 30 (59) 15 (68)
Undilated indirect ophthalmoscopy* 39 (53) 23 (45) 16 (73)
Dilated indirect ophthalmoscopy 15 (20) 9 (18) 6 (27)
Dilated retinal photography 11 (15) 8 (16) 3 (14)
Undilated direct ophthalmoscopy* 11 (15) 11 (22) 0 (0)
Available instruments for retinal
examination and imaging, n (%)
Direct ophthalmoscope and/or indirect
slit-lamp ophthalmoscopy
71 (96) 48 (94) 22 (100)
Retinal fundus camera 65 (88) 44 (86) 20 (91)
Scanning-laser ophthalmoscope
(Optomap)
19 (26) 10 (20) 9 (41)
a Missing data for 1 participant.
Student t-test P*<0.05 and P**<0.01 between optometrists with and without
MSc in clinical optometry.
Table 1 Characteristics of Norwegian optometrists
Members of NOFa
All members
(n=1028)
Non-participants
(n=954)
Participants
(n=74)
Gender n, (%)
Male 472 (46) 441 (46) 31 (42)
Female 556 (54) 513 (54) 43 (58)
Practice by national
health region n, (%)
East 338 (33) 317 (33) 21 (28)
South 293 (29) 276 (29) 20 (27)
West 176 (17) 165 (17) 11 (15)
Middle 135 (13) 119 (12) 16 (22)
North 83 (8) 77 (8) 6 (8)
Higher education n, (%)
Master of science in
clinical optometry b,*
200 (20) 178 (19) 22 (30)
Private optometric
practice n, (%) ‡
870 (88) 796 (87) 74 (100)
Information as registered by the Norwegian Association of Optometry (NOF)
and reported by the participating optometrists.
a Members of the NOA February 2011.
b Missing data for 37 optometrists.
Pearson Chi-square P*< 0.05 between participants and non-participants.
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We have found that sensitivity, but not specificity, was
influenced by the level of formal education the partici-
pants had received. Optometrists with an MSc had a sig-
nificantly higher sensitivity than optometrist with a basic
optometric education. This suggests that our results give
a better estimate of sensitivity and specificity in general
optometric practice, as our study included optometrists
who had not had any special training in screening
for DR.
The sensitivity observed in this study is in line with
that observed in a previous study we undertook to investi-
gate Norwegian general optometric practice [23], where
sensitivity ranged from 61% to 65%, based on an assump-
tion of 14% prevalence of DR among patients with diabetes
[3]. Specificity in the current study was, however, lower
than in our previous study (84% vs. 98-100%), which could
be explained by the difference in prevalence between the
two studies. In the current study, 98% of findings of DR
(both true- and false-positives) were considered to warrant
a report/referral to a physician. This is higher than the rate
of 57% reported in a national practice registration in Nor-
way [23]. The experimental design in our study, where
optometrists were blinded to patient information but
assumed that the patient had never been examined by an
Table 3 Optometrists’ VIMOC evaluations of retinal images and corresponding ophthalmologist grading and patient
glucose status
Image evaluation Optometrist consideration on further management
Imagea Patient status Ophthalmologists grading of DR Optometrists true
findings of DR
No/Routine
follow-up
Report / referral
to general
practitioner
Report / referral to
ophthalmologist
n % (95%CI) n % (95%CI) n % (95%CI) n % (95%CI)
8 IGT No DR 46 64 (52 to 75) 17 37 (23 to 51) 21 46 (31 to 60) 8 17 (6 to 28)
5 KDM No DR 53 72 (61 to 82) 30 37 (43 to 70) 10 19 (8 to 29) 13 25 (13 to 36)
14 SDDM No DR 61 82 (74 to 91) 31 51 (38 to 63) 18 30 (18 to 41) 12 20 (10 to 30)
13 SDDM No DR 64 86 (79 to 94) 33 52 (39 to 64) 10 16 (7 to 25) 21 33 (21 to 44)
12 SDDM No DR 68 92 (86 to 98) 58 85 (77 to 94) 4 6 (0 to 11) 6 9 (2 to 16)
11 KDM No DR 71 96 (91 to 100) 61 86 (78 to 94) 2 3 (0 to 7) 8 11 (4 to 19)
2 NGT No DR 73 99 (96 to 100) 66 90 (84 to 97) 4 5 (0 to 11) 3 4 (0 to 9)
1 NGT Mild NPDR 23 31 (20 to 42) 1 4 (0 to 13) 8 35 (15 to 54) 14 61 (41 to 81)
6 IGT Mild NPDR 39 53 (41 to 64)) 1 3 (0 to 8) 10 26 (12 to 39) 28 72 (58 to 86)
3 NGT Mild NPDR 40 54 (42 to 66) 0 0 (0 to 0) 19 48 (32 to 63) 21 53 (37 to 68)
7 DM Mild NPDR 41 55 (44 to 67) 1 2 (0 to 7) 15 37 (22 to 51) 25 61 (46 to 76)
4 DM Mild NPDR 57 77 (67 to 87) 2 4 (0 to 8) 20 35 (23 to 47) 35 61 (49 to 74)
9b DM Moderate NPDR 71 100 (100 to 100) 0 0 (0 to 0) 4 6 (0 to 11) 67 94 (89 to100)
10c DM Moderate NPDR 73 100 (100 to 100) 0 0 (0 to 0) 8 11 (4 to 18) 65 89 (82 to 96)
CI, confidence interval; DR, diabetic retinopathy; IGT, impaired glucose tolerance; KDM, known diabetes; NGT, normal glucose tolerance; NPDR, non-proliferative
diabetic retinopathy; SDDM, screen-detected diabetes; VIMOC, Visual Identification and Management of Ophthalmological Conditions. a The number refers to the
number in image presentation sequence of the VIMOC examinationMissing grading data from b3 and c1 optometrists.
Table 4 Optometrists’ sensitivity and specificity for identifying diabetic retinopathy, presented by formal education level
Sensitivity Specificity
Any DR (n=7) Mild DR (n=5) Moderate DR (n=2) No DR (n=7)
% (95%CI) % (95%CI) % (95%CI) % (95%CI)
All optometrists (n=74) 67 (62 to 72) 54 (47 to 61) 100 84 (80 to 89)
Formal education a,**
BSc or lower (n=51) 63 (56 to 69) 48 (39 to 57) 100 84 (78 to 89)
MSc (n= 22) 77 (71 to 84) 68 (59 to 77) 100 85 (77 to 93)
BSc, Bachelor of science; CI, confidence interval; DR, diabetic retinopathy; MSc, master of science.
a Missing data for 1 optometrist.
Student t-test P**<0.01 statistically significant difference in sensitivity between optometrists with MSc and optometrists with BSc or even lower formal education.
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ophthalmologist, may have led to an increased tendency to
recommend referral to a physician.
Assuming the prevalence of DR is 14% [3], the nega-
tive and positive predictive values of the optometrists’
evaluation of DR in our study would be 94% and 41%,
respectively. Based on this and on the fact that Norwe-
gian optometrists undertake approximately 1 million eye
examinations per year (of which approximately 4% are in
patients with diabetes [30]), our findings suggest that
each year approximately 5500 patients without DR are
referred based on a false positive result, while in
approximately 1300 patients with DR, no further action
is taken. However, if the British Diabetic Association
screening criteria were met in Norwegian optometric
practice, these figures would be 1700 and 800, respect-
ively. Our results suggest that an excessive workload is
being placed on healthcare services by inaccurate refer-
ral practices. However, the national guidelines recom-
mend eye examination by ophthalmologists [20,21], thus
the report/referral of a patient who has not previously
been seen by an ophthalmologist should not be discour-
aged. Of greater concern is the false security given to
Table 5 Individual image evaluation and suggested follow-up
Images with diabetic retinopathy (n=518) Images without diabetic retinopathy (n=518)
True positive sensitivity False negative True negative specificity False positive
n % n % n % n %
Screening standard set to meet a 414 80 104 20 492 95 26 5
n % (95%CI) n % (95%CI) n % (95%CI) n % (95%CI)
Optometrists’ image evaluation 348 67 (62 to 72) 170 32 (28 to 38) 437 84 (80 to 89) 81 16 (11 to 20)
Further managementb
None / Routine follow up 5 1 (0 to 3) 113 66 (59 to 74) 296 68 (64 to 72) 3 4 (0 to 8)
Report / referral to general practitioner 84 24 (20 to 29) 41 24 (18 to 21) 69 16 (12 to 19) 39 48 (37 to 59)
Report / referral to ophthalmologist 255 74 (70 to 79) 16 9 (5 to 14) 71 16 (13 to 20) 39 48 (37 to 59)
a British Diabetic Association. Retinal photographic screening for diabetic eye disease. A British Diabetic Association Report. London:
British Diabetic Association; 1997.
b Data missing for 5 image evaluations.
Table 6 Optometrists’ sensitivity and specificity for identifying diabetic retinopathy as reported in the current study
and previous studies
Sensitivity (95%CI) Specificity (95%CIn
Study Retinal examination method ADR STDR ADR STDR
Our study (2011)
Community optometrists Image evaluation of digital images 67 (62 to 72) 84 (80 to 89)
Harvey et al (2006)
Optometrists in a screening program Not available 80 (71 to 89) 99 (98 to 100)
Olson et al (2003)
Specially trained optometrists Dilated slit-lamp examination 73 (52 to 88) 90 (87 to 93)
Schmid et al (2002)
Community optometrists Ophthalmoscopy (free choice) 92 (84 to 100) 94 (90 to 98)
Image evaluation of retinal slides 94 (90 to 98) 97 (92 to 100)
Hulme et al (2001)
Specially trained optometrists Dilated slit-lamp examination 72 87 77 91
Prasad et al (2001)
Specially trained optometrists Dilated slit-lamp examination 66 (65 to 67) 76 (70 to 81) 97 (97 to 98) 95 (95 to 96)
Gibbins et al (1998)
Community optometrists Image evaluation of 35 mm slides 88 (83 to 93) 91 (79 to 98) 68 (58 to 68) 83 (79 to 87)
Specially trained optometrist Image evaluation of 35 mm slides 86 (81 to 91) 97 (90 to 100) 89 (85 to 93) 87 (84 to 91)
Buxton et al (1991)
Community optometrists Image evaluation of Polaroid images 48 (26 to 69) 94 (92 to 97)
ADR, any diabetic retinopathy, STDR, sight-threatening diabetic retinopathy.
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those patients with DR who are not referred to an
ophthalmologist.
The strengths of this study are the use of standardised
images in the VIMOC exam and the use of a diagnostic
“gold standard” based on 100% agreement between two
independent ophthalmologists. The experimental design
allowed the calculation of sensitivity and specificity with
acceptable precision in a relatively large nationwide sam-
ple of optometrists, something that was not achieved in
previous studies [25-28,34]. In terms of gender, number
of years in practice and geographical location, our sam-
ple of optometrists is representative of members of the
NOF and of optometrists who participated in a previous
study of Norwegian optometric practice [23,30]. The po-
tential for knowledge bias and overestimation of sensi-
tivity and specificity for general optometric practice was
reduced in the current study because the optometrists
were not provided with grading scales, nor were they
given specific training prior to the study.
One potential limitation of the study was the possibil-
ity of selection bias, as optometrists with a specific inter-
est in diabetes may have been more likely to accept the
invitation to participate and hence may have been over-
represented in the study. This could have inflated the
sensitivity levels observed, compared with general opto-
metric practice. On the other hand, participating opto-
metrists did not have specific training in screening for
DR, nor were they provided with a DR grading scale or a
computer screen that would facilitate classification of
DR. Variable viewing conditions may have influenced
the detection rate of DR. Small screen size, low screen
resolution and inadequate colour setting may have led to
lower sensitivity for detecting mild DR. On the other
hand, the optometrists’ use of their own facilities simu-
lated real practice, something that the use of perfect
viewing conditions could not have done.
Conclusions
Our study is likely to have given a better representation
of general optometric practice than previous studies
[25-28,34]. However, our findings indicate that at present
case-finding of DR in Norwegian optometric practice is
unreliable. Formal optometric training in screening for
DR and continuing education may improve diagnostic
sensitivity. Further research will be needed to evaluate the
effectiveness of measures undertaken to improve optome-
trists’ diagnostic accuracy for case-finding of DR.
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